Harriet de Wit
Professor of Psychiatry at the University of Chicago
Data updated
Research Footprint
Harriet de Wit appears in 32 tracked papers (2010–2026), most studied alongside MDMA, LSD and Placebo, across Healthy Volunteers, Interpersonal Functioning & Social Connectedness and Microdosing.
Most-cited paper: Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others (245 citations).
Frequent co-authors: Anya Bershad, Richard Lee and Matthew Kirkpatrick.
Publication Landscape
How the 32 papers Blossom tracks for Harriet de Wit line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Harriet de Wit's publishing grown?
SourcedTracked papers by publication year; 1 earlier paper published before 2012. Click a year for the running total.
Don't read as total output: only the 32 of 32 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Harriet de Wit publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Harriet de Wit publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Dr. Harriet de Wit is the Director of the Human Behavioral Pharmacology Laboratory at the University of Chicago. Her extensive research focuses on the physiological, subjective, and behavioral effects of drugs in healthy human volunteers. In the psychedelic field, she investigates individual differences in response to LSD and MDMA, aiming to understand the underlying mechanisms of motivated behavior and drug-induced mood changes.
Key Impact
A pioneer in human behavioral pharmacology with over 40 years of research on the effects of psychoactive drugs.
Collaboration Network
13 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Harriet de Wit's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Harriet de Wit is associated with.